Inferior vena cava filters

Jayer Chung, Thomas F. Dodson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The incidence of first-time venous thromboembolic (VTE) events is approximately 70–113 cases per 100,000 people per year. Approximately one-third of these cases are due to pulmonary embolism (PE). Venous thromboembolism will recur in approximately 7% of patients at 6 months, with patients presenting with PE more likely to have recurrent PE. Thirty-day mortality following PE is approximately 12%. While anti-coagulation remains the gold-standard therapy for VTE, patients who have recurrent PE despite adequate anticoagulation, high-risk patients with contraindications to anticoagulation, or patients who have bleeding complications while on anticoagulation therapy meet criteria for inferior vena cava (IVC) filter placement. Inferior vena cava filter placement is contraindicated in patients with complete thrombosis of the IVC, or with an IVC that is otherwise inaccessible by percutaneous means. Inferior vena cava filters are inserted percutaneously under local anesthesia via the femoral or jugular vein, with fluoroscopic or ultrasound guidance. The procedure usually takes less than 30 minutes, and consists of obtaining central venous access under ultrasound guidance. Venography is performed; fluoroscopic guidance may be used to measure the IVC, locate the renal veins, and identify any possible aberrant anatomy. Procedural morbidity is extremely rare and consists primarily of complications at the insertion site. Long-term complications are more significant and need to be considered when placing filters in young patients. Such complications include device migration, device fracture, caval thrombosis, IVC perforation, and post-thrombotic syndrome.

Original languageEnglish (US)
Title of host publicationMedical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition
PublisherCambridge University Press
Pages627-628
Number of pages2
ISBN (Print)9780511920660, 9781107009165
DOIs
StatePublished - Jan 1 2010

Fingerprint

Vena Cava Filters
Pulmonary Embolism
Inferior Vena Cava
Thrombosis
Equipment and Supplies
Venae Cavae
Renal Veins
Femoral Vein
Phlebography
Femur Neck
Venous Thromboembolism
Jugular Veins
Local Anesthesia
Gold
Anatomy
Hemorrhage
Morbidity
Mortality
Incidence
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chung, J., & Dodson, T. F. (2010). Inferior vena cava filters. In Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition (pp. 627-628). Cambridge University Press. https://doi.org/10.1017/CBO9780511920660.092

Inferior vena cava filters. / Chung, Jayer; Dodson, Thomas F.

Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press, 2010. p. 627-628.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chung, J & Dodson, TF 2010, Inferior vena cava filters. in Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press, pp. 627-628. https://doi.org/10.1017/CBO9780511920660.092
Chung J, Dodson TF. Inferior vena cava filters. In Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press. 2010. p. 627-628 https://doi.org/10.1017/CBO9780511920660.092
Chung, Jayer ; Dodson, Thomas F. / Inferior vena cava filters. Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press, 2010. pp. 627-628
@inbook{ca061b3b2c6944e3913e50e5e0b21dcc,
title = "Inferior vena cava filters",
abstract = "The incidence of first-time venous thromboembolic (VTE) events is approximately 70–113 cases per 100,000 people per year. Approximately one-third of these cases are due to pulmonary embolism (PE). Venous thromboembolism will recur in approximately 7{\%} of patients at 6 months, with patients presenting with PE more likely to have recurrent PE. Thirty-day mortality following PE is approximately 12{\%}. While anti-coagulation remains the gold-standard therapy for VTE, patients who have recurrent PE despite adequate anticoagulation, high-risk patients with contraindications to anticoagulation, or patients who have bleeding complications while on anticoagulation therapy meet criteria for inferior vena cava (IVC) filter placement. Inferior vena cava filter placement is contraindicated in patients with complete thrombosis of the IVC, or with an IVC that is otherwise inaccessible by percutaneous means. Inferior vena cava filters are inserted percutaneously under local anesthesia via the femoral or jugular vein, with fluoroscopic or ultrasound guidance. The procedure usually takes less than 30 minutes, and consists of obtaining central venous access under ultrasound guidance. Venography is performed; fluoroscopic guidance may be used to measure the IVC, locate the renal veins, and identify any possible aberrant anatomy. Procedural morbidity is extremely rare and consists primarily of complications at the insertion site. Long-term complications are more significant and need to be considered when placing filters in young patients. Such complications include device migration, device fracture, caval thrombosis, IVC perforation, and post-thrombotic syndrome.",
author = "Jayer Chung and Dodson, {Thomas F.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1017/CBO9780511920660.092",
language = "English (US)",
isbn = "9780511920660",
pages = "627--628",
booktitle = "Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Inferior vena cava filters

AU - Chung, Jayer

AU - Dodson, Thomas F.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The incidence of first-time venous thromboembolic (VTE) events is approximately 70–113 cases per 100,000 people per year. Approximately one-third of these cases are due to pulmonary embolism (PE). Venous thromboembolism will recur in approximately 7% of patients at 6 months, with patients presenting with PE more likely to have recurrent PE. Thirty-day mortality following PE is approximately 12%. While anti-coagulation remains the gold-standard therapy for VTE, patients who have recurrent PE despite adequate anticoagulation, high-risk patients with contraindications to anticoagulation, or patients who have bleeding complications while on anticoagulation therapy meet criteria for inferior vena cava (IVC) filter placement. Inferior vena cava filter placement is contraindicated in patients with complete thrombosis of the IVC, or with an IVC that is otherwise inaccessible by percutaneous means. Inferior vena cava filters are inserted percutaneously under local anesthesia via the femoral or jugular vein, with fluoroscopic or ultrasound guidance. The procedure usually takes less than 30 minutes, and consists of obtaining central venous access under ultrasound guidance. Venography is performed; fluoroscopic guidance may be used to measure the IVC, locate the renal veins, and identify any possible aberrant anatomy. Procedural morbidity is extremely rare and consists primarily of complications at the insertion site. Long-term complications are more significant and need to be considered when placing filters in young patients. Such complications include device migration, device fracture, caval thrombosis, IVC perforation, and post-thrombotic syndrome.

AB - The incidence of first-time venous thromboembolic (VTE) events is approximately 70–113 cases per 100,000 people per year. Approximately one-third of these cases are due to pulmonary embolism (PE). Venous thromboembolism will recur in approximately 7% of patients at 6 months, with patients presenting with PE more likely to have recurrent PE. Thirty-day mortality following PE is approximately 12%. While anti-coagulation remains the gold-standard therapy for VTE, patients who have recurrent PE despite adequate anticoagulation, high-risk patients with contraindications to anticoagulation, or patients who have bleeding complications while on anticoagulation therapy meet criteria for inferior vena cava (IVC) filter placement. Inferior vena cava filter placement is contraindicated in patients with complete thrombosis of the IVC, or with an IVC that is otherwise inaccessible by percutaneous means. Inferior vena cava filters are inserted percutaneously under local anesthesia via the femoral or jugular vein, with fluoroscopic or ultrasound guidance. The procedure usually takes less than 30 minutes, and consists of obtaining central venous access under ultrasound guidance. Venography is performed; fluoroscopic guidance may be used to measure the IVC, locate the renal veins, and identify any possible aberrant anatomy. Procedural morbidity is extremely rare and consists primarily of complications at the insertion site. Long-term complications are more significant and need to be considered when placing filters in young patients. Such complications include device migration, device fracture, caval thrombosis, IVC perforation, and post-thrombotic syndrome.

UR - http://www.scopus.com/inward/record.url?scp=84923514482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923514482&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511920660.092

DO - 10.1017/CBO9780511920660.092

M3 - Chapter

AN - SCOPUS:84923514482

SN - 9780511920660

SN - 9781107009165

SP - 627

EP - 628

BT - Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition

PB - Cambridge University Press

ER -